The pathologic continuum of diabetic vascular disease.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 19179216.
- Also identified by DOI 10.1016/j.jacc.2008.09.055 and PMC identifier 2663393.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hyperglycemia can promote vascular complications by multiple mechanisms, with formation of advanced glycation end products and increased oxidative stress proposed to contribute to both macrovascular and microvascular complications. Many of the earliest pathologic responses to hyperglycemia are manifest in the vascular cells that directly encounter elevated blood glucose levels. In the macrovasculature, these include endothelial cells and vascular smooth muscle cells. In the microvasculature, these include endothelial cells, pericytes (in retinopathy), and podocytes (in renal disease). Additionally, neovascularization arising from the vasa vasorum may promote atherosclerotic plaque progression and contribute to plaque rupture, thereby interconnecting macroangiopathy and microangiopathy.
Medical subject headings
- Cardiovascular Diseases
- Diabetes Complications
- Diabetes Mellitus, Type 2
- Neovascularization, Pathologic